Sumitomo Pharma Co., Ltd. (TYO: 4506)
Japan
· Delayed Price · Currency is JPY 593.00
-12.00 (-1.98%)
Nov 20, 2024, 3:45 PM JST
Sumitomo Pharma Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 342,665 | 314,558 | 555,544 | 560,035 | 515,952 | 482,732 | Upgrade
|
| Revenue Growth (YoY) | -11.89% | -43.38% | -0.80% | 8.54% | 6.88% | 5.11% | Upgrade
|
| Cost of Revenue | 138,581 | 126,577 | 178,919 | 157,127 | 137,773 | 129,673 | Upgrade
|
| Gross Profit | 204,084 | 187,981 | 376,625 | 402,908 | 378,179 | 353,059 | Upgrade
|
| Selling, General & Admin | 353,657 | 397,705 | 339,212 | 217,339 | 173,666 | 143,076 | Upgrade
|
| Research & Development | 88,553 | 112,637 | 131,858 | 94,903 | 132,682 | 115,112 | Upgrade
|
| Other Operating Expenses | 6,858 | 942 | -2,200 | -1,043 | 825 | 677 | Upgrade
|
| Operating Expenses | 480,901 | 543,117 | 502,974 | 342,941 | 323,880 | 270,137 | Upgrade
|
| Operating Income | -276,817 | -355,136 | -126,349 | 59,967 | 54,299 | 82,922 | Upgrade
|
| Interest Expense | -55,652 | -3,893 | -2,640 | -2,970 | -2,436 | -699 | Upgrade
|
| Interest & Investment Income | - | 2,839 | 5,486 | 1,175 | 1,153 | 3,564 | Upgrade
|
| Currency Exchange Gain (Loss) | 32,829 | 32,829 | 26,308 | 24,530 | 8,037 | -1,134 | Upgrade
|
| Other Non Operating Income (Expenses) | -30 | -30 | -95 | -8 | -127 | -1,023 | Upgrade
|
| EBT Excluding Unusual Items | -299,670 | -323,391 | -97,290 | 82,694 | 60,926 | 83,630 | Upgrade
|
| Gain (Loss) on Sale of Investments | -224 | -224 | 24,735 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 501 | 501 | 24,635 | 267 | 16,925 | 317 | Upgrade
|
| Pretax Income | -299,393 | -323,114 | -47,920 | 82,961 | 77,851 | 83,947 | Upgrade
|
| Income Tax Expense | -19,972 | -8,185 | 48,794 | 42,361 | 41,022 | 48,029 | Upgrade
|
| Earnings From Continuing Operations | -279,421 | -314,929 | -96,714 | 40,600 | 36,829 | 35,918 | Upgrade
|
| Minority Interest in Earnings | -36 | -40 | 22,202 | 15,813 | 19,390 | 4,835 | Upgrade
|
| Net Income | -279,457 | -314,969 | -74,512 | 56,413 | 56,219 | 40,753 | Upgrade
|
| Net Income to Common | -279,457 | -314,969 | -74,512 | 56,413 | 56,219 | 40,753 | Upgrade
|
| Net Income Growth | - | - | - | 0.35% | 37.95% | -16.19% | Upgrade
|
| Shares Outstanding (Basic) | 397 | 397 | 397 | 397 | 397 | 397 | Upgrade
|
| Shares Outstanding (Diluted) | 397 | 397 | 397 | 397 | 397 | 397 | Upgrade
|
| Shares Change (YoY) | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | Upgrade
|
| EPS (Basic) | -703.41 | -792.79 | -187.55 | 141.99 | 141.50 | 102.58 | Upgrade
|
| EPS (Diluted) | -703.41 | -792.79 | -187.55 | 141.99 | 141.50 | 102.58 | Upgrade
|
| EPS Growth | - | - | - | 0.35% | 37.95% | -16.19% | Upgrade
|
| Free Cash Flow | -73,425 | -252,664 | 3,470 | 23,892 | 129,553 | 38,406 | Upgrade
|
| Free Cash Flow Per Share | -184.81 | -635.97 | 8.73 | 60.14 | 326.09 | 96.67 | Upgrade
|
| Dividend Per Share | - | - | 21.000 | 28.000 | 28.000 | 28.000 | Upgrade
|
| Dividend Growth | - | - | -25.00% | 0% | 0% | 7.69% | Upgrade
|
| Gross Margin | 59.56% | 59.76% | 67.79% | 71.94% | 73.30% | 73.14% | Upgrade
|
| Operating Margin | -80.78% | -112.90% | -22.74% | 10.71% | 10.52% | 17.18% | Upgrade
|
| Profit Margin | -81.55% | -100.13% | -13.41% | 10.07% | 10.90% | 8.44% | Upgrade
|
| Free Cash Flow Margin | -21.43% | -80.32% | 0.62% | 4.27% | 25.11% | 7.96% | Upgrade
|
| EBITDA | -244,022 | -317,371 | -85,086 | 98,315 | 76,972 | 100,287 | Upgrade
|
| EBITDA Margin | -71.21% | -100.89% | -15.32% | 17.56% | 14.92% | 20.77% | Upgrade
|
| D&A For EBITDA | 32,795 | 37,765 | 41,263 | 38,348 | 22,673 | 17,365 | Upgrade
|
| EBIT | -276,817 | -355,136 | -126,349 | 59,967 | 54,299 | 82,922 | Upgrade
|
| EBIT Margin | -80.78% | -112.90% | -22.74% | 10.71% | 10.52% | 17.18% | Upgrade
|
| Effective Tax Rate | - | - | - | 51.06% | 52.69% | 57.21% | Upgrade
|
| Advertising Expenses | - | 42,372 | 59,857 | 37,780 | 37,362 | 37,745 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.